The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A novel clinical decision aid to support personalized treatment selection for patients with CT1 renal cortical masses: Results from a multi-institutional competing risks analysis including performance status and comorbidity.
 
Sarah P. Psutka
Honoraria - Prime Education
Consulting or Advisory Role - Nucleix
Travel, Accommodations, Expenses - Prime Education
 
Roman Gulati
No Relationships to Disclose
 
Michael A.S. Jewett
Stock and Other Ownership Interests - Theralase
Honoraria - Pfizer
Consulting or Advisory Role - Theralase
Patents, Royalties, Other Intellectual Property - Patent application filed for a new RFA device
 
Kamel Fadaak
No Relationships to Disclose
 
Antonio Finelli
Stock and Other Ownership Interests - Abbvie; Bristol-Myers Squibb
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Ipsen; Janssen Oncology; Roche Canada; Tersera
Consulting or Advisory Role - Abbvie; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Tersera
Travel, Accommodations, Expenses - TerSera
 
Todd Matthew Morgan
Consulting or Advisory Role - Myriad Genetics; TERUMO
Research Funding - GenomeDx (Inst); MDxHealth (Inst); Myriad Genetics (Inst)
 
Phillip M. Pierorazio
No Relationships to Disclose
 
Mohamad E. Allaf
Research Funding - Progenics (Inst)
 
Jeph Herrin
No Relationships to Disclose
 
Christine M. Lohse
No Relationships to Disclose
 
R. Houston Thompson
Patents, Royalties, Other Intellectual Property - Patent for B7-H1 and survivin as prognostic markers in renal cell carcinoma.
 
Stephen A. Boorjian
Consulting or Advisory Role - Ferring; Sanofi
 
Thomas D. Atwell
No Relationships to Disclose
 
Grant Schmit
No Relationships to Disclose
 
Brian Addis Costello
Research Funding - GlaxoSmithKline/Novartis (Inst)
 
Laura Legere
No Relationships to Disclose
 
Nilay Shah
No Relationships to Disclose
 
Bradley C. Leibovich
No Relationships to Disclose